Asiatic Drugs & Pharmaceuticals Private Limited

Happenings / News / Press Coverage

Latest Pharma News (Extract from worldpharmanews.com)

Researchers from VTT Technical Research Centre of Finland and the University of Turku have discovered four metabolic enzymes egulating prostate cancer cell growth. Inhibition of these enzymes prevents prostate cancer cell growth in cultured cells. This knowledge can be used to identify different subtypes of prostate cancer and for designing targeted therapies for prostate cancer.

Eicosanoid hormones, which are metabolites of arachidonic acid found in animal-based foods, such as eggs and meat, are essential regulators of normal bodily functions. Metabolic dysfunction relating to these bioactive lipids plays a role in many diseases. Prostate cancer cells use increased arachidonic acid metabolism and eicosanoid production to fuel their enhanced growth.

Infrastructure

The Factory has been set up on a plot of land measuring 8,100 sq. meters in the approved industrial area of Rajasthan Industrial & Investment Corporation Limited. Facility for production of Cefixime Trihydrate (100 TPA) including its intermediates like 7-AVCA and Cefixime Methyl Ester has been created. The products conform to the specifications of British Pharmacopeia. United States Pharmacopoeia and Indian Pharmacopoeia. The Unit has a well-equipped Quality Control Laboratory.

	Fact Sheet Nature of Business : Manufacturer Major Markets : Indian Subcontinent

Contact Details

Company Name: Asiatic Drugs & Pharmaceuticals Private Limited Contact Person: Mr. Manager Telephone: +(91)-(11)-26460407 / 26412720 / 41616836 Fax No: +(91)-(11)-41616837 Address: No. 505, Saraswati House, No. 27, Nehru Place, New Delhi, Delhi - 110 019 (India)